RADIOPHARM THERANOSTICS LTD (RADX) Stock Income Statement
NASDAQ:RADX - Nasdaq - ADR - Currency: USD
| TTM (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.68M | 299.20K | 292.40K | 0.00 | 0.00 | |||
| Operating Expenses | 37.83M | 37.42M | 34.52M | 19.92M | 484.80K | |||
| Research and Development | 21.58M | 19.97M | 22.03M | 4.51M | N/A | |||
| Selling, General, and Administrative Expenses | 14.68M | 15.67M | 15.26M | 12.44M | 484.80K | |||
| Operating Income | -37.76M | -37.12M | -34.23M | -19.92M | -484.80K | |||
| Interest Income/Expense | -3.68M | -10.73M | -343.30K | -10.46M | N/A | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -400.00 | |||
| Income Before Taxes | -42.67M | -47.85M | -34.57M | -30.38M | -485.20K | |||
| Income Tax | 166.20K | 96.40K | 38.00K | 44.40K | 0.00 | |||
| Net Income | -41.92M | -47.95M | -34.61M | -30.42M | -485.20K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -15.15 | -29.28 | -25.23 | -36.15 | -0.45 | |||
| Statistics | ||||||||
| Profit Margin | -2490.72% | -16025.77% | -11836.94% | N/A | N/A | |||
| Operating Profit Margin | -2243.81% | -12407.55% | -11706.53% | N/A | N/A | |||
All data in AUD